2,829
Views
9
CrossRef citations to date
0
Altmetric
Review Article

Novel cutaneous mediators of chemical allergy

, &
Pages 13-27 | Received 15 Jun 2018, Accepted 20 Aug 2018, Published online: 01 Mar 2019

References

  • Aalto-Korte K, Suuronen K, Kuuliala O, Henriks-Eckerman M, Jolanki R. 2012. Occupational contact allergy to monomeric isocyanates. Cont Derm. 67:78–88.
  • Ainscough J, Gerberick G, Dearman R, Kimber I. 2013. Danger, intracellular signaling, and the orchestration of dendritic cell function in skin sensitization. J Immunotoxicol. 10:223–234.
  • Albanesi C, Cavani A, Girolomoni G. 1999. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: Synergistic or antagonist effects with IFN-γ and TNF-α. J Immunol. 162:494–502.
  • Anderson S, Franko J, Kashon M, Anderson K, Hubbs A, Lukomska E, Meade B. 2013. Exposure to triclosan augments the allergic response to ovalbumin in a mouse model of asthma. Toxicol Sci. 132:96–106.
  • Anderson S, Umbright C, Sellamuthu R, Fluharty K, Kashon M, Franko J, Jackson L, Johnson V, Joseph P. 2010. Irritancy and allergic responses induced by topical application of o-phthalaldehyde. Toxicol Sci. 115:435–443.
  • Anderson S, Beezhold K, Lukomska E, Richardson J, Long C, Anderson K, Franko J, Meade B, D. H. Beezhold D. 2014. Expression kinetics of miRNA involved in dermal toluene 2,4-diisocyanate sensitization. J Immunotoxicol. 11:250–259.
  • Anderson S, Shane H, Long C, Lukomska E, Meade B, Marshall N. 2016. Evaluation of the irritancy and hypersensitivity potential following topical application of didecyldimethylammonium chloride. J Immunotoxicol. 13:557–566.
  • Artis D, Spits H. 2015. The biology of innate lymphoid cells. Nature. 517:293–301.
  • Askenase P, van Loveren H, Kraeuter-Kops S, Ron Y, Meade R, Theoharides T, Nordlund J, Scovern H, Gerhson M, Ptak W. 1983. Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice. J Immunol. 131:2687–2694.
  • Baeck M, Soria A, Marot L, Theate I, Hendrickx E, van Belle A, Goossens A, Tennstedt D, Dachelet C, Jaeger J, et al. 2013. Characterization of the T-cell response in allergic contact dermatitis caused by corticosteroids. Cont Derm. 68:357–368.
  • Bangert C, Brunner PM, Stingl G. 2011. Immune functions of the skin. Clin Dermatol. 29:360–376.
  • Banovac K, Neylan D, Leone J, Ghandur-Mnaymneh L, Rabinovitch A. 1989. Are the mast cells antigen-presenting cells?. Immunol Invest. 18:901–906.
  • Bello D, Herrick C, Smith T, Woskie S, Streicher R, Cullen M, Liu Y, Redlich C. 2007. Skin exposure to isocyanates: Reasons for concern. Environ. Health Perspect 115:328–335.
  • Biedermann T, Kneilling M, Mailhammer R, Maier K, Sander C, Kollias G, Kunkel S, Hultner L, Rocken M. 2000. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med. 192:1441–1452.
  • Bonefeld C, Geisler C, Gimenez-Arnau E, Lepoittevin J, Uter W, Johansen J. 2017. Immunological, chemical and clinical aspects of exposure to mixtures of contact allergens. Cont Derm. 77:133–142.
  • Brand S, Kesper D, Teich R, Kilic-Niebergall E, Pinkenburg O, Bothur E, Lohoff M, Garn H, Pfefferle P, Renz H. 2012. DNA methylation of TH1/TH2 cytokine genes affects sensitization and progress of experimental asthma. J Allergy Clin Immunol. 129:1602–1610.
  • Budinger L, Hertl M. 2000. Immunologic mechanisms in hypersensitivity reactions to metal ions: An overview. Allergy. 55:108–115.
  • Chapman V, Terranova R, Moggs J, Kimber I, Dearman R. 2016. Evaluation of 5-methylcytosine and 5-hydroxymethylcytosine as potential biomarkers for characterization of chemical allergens. Toxicology. 340:17–26.
  • Chapman V, Zollinger T, Terranova R, Moggs J, Kimber I, Dearman R. 2014. Chemical allergen induced perturbations of the mouse lymph node DNA methylome. Toxicol Sci. 139:350–361.
  • Chipinda I, Hettick J, Siegel P. 2011. Haptenation: Chemical reactivity and protein binding. J Allergy (Cairo). 2011:839682.
  • Chow Z, Mueller S, Deane J, Hickey M. 2013. Dermal regulatory T cells display distinct migratory behavior that is modulated during adaptive and innate inflammation. J Immunol. 191:3049–3056.
  • Christensen A, Haase C. 2012. Immunological mechanisms of contact hypersensitivity in mice. APMIS. 120:1–27.
  • Christensen A, Skov S, Kvist P, Haase C. 2015. Depletion of regulatory T-cells in a hapten-induced inflammation model results in prolonged and increased inflammation driven by T-cells. Clin Exp Immunol. 179:485–499.
  • Cianferoni A, Spergel J. 2014. The importance of TSLP in allergic disease and its role as a potential therapeutic target. Expert Rev Clin Immunol. 10:1463–1474.
  • Ciprandi G, de Amici M, Giunta V, Marseglia A, Marseglia G. 2013. Serum interleukin-9 levels are associated with clinical severity in children with atopic dermatitis. Pediatr Dermatol. 30:222–225.
  • Coombs P. 1963. The classification of allergic reactions underlying disease. In: Gell P, ed. Clinical aspects of immunology. Oxford: Blackwell. pages 317–337.
  • Corthay A. 2009. How do regulatory T-cells work?. Scand J Immunol. 70:326–336.
  • Cosmi L, Liotta F, Maggi E, Romagnani S, Annunziato F. 2011. TH17 cells: New players in asthma pathogenesis. Allergy. 66:989–998.
  • Cumberbatch M, Scott R, Basketter D, Scholes E, Hilton J, Dearman R, Kimber I. 1993. Influence of sodium lauryl sulphate on 2,4-dinitrochlorobenzene-induced lymph node activation. Toxicology 77:181–191.
  • Curtsinger J, Mescher M. 2010. Inflammatory cytokines as a third signal for T cell activation. Curr Opin Immunol. 22:333–340.
  • de Filippo K, Dudeck A, Hasenberg M, Nye E, van Rooijen N, Hartmann K, Gunzer M, Roers A, Hogg N. 2013. Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood. 121:4930–4937.
  • de Vooght V, Cruz M, Haenen S, Wijnhoven K, Munoz X, Hoet P, Morell F, Nemery N, Vanoirbeek J. 2010. Ammonium persulfate can initiate an asthmatic response in mice. Thorax. 65:252–257.
  • Dearman R, Basketter D, Kimber I. 1996. Characterization of chemical allergens as a function of divergent cytokine secretion profiles induced in mice. Toxicol Appl Pharmacol. 138:308–316.
  • Dhingra N, Guttman-Yassky E. 2014. A possible role for IL-17A in establishing TH2 inflammation in murine models of atopic dermatitis. J Invest Dermatol. 134:2071–2074.
  • Dieli F, Ptak W, Sireci G, Romano G, Potestio M, Salerno A, Asherson G. 1998. Cross-talk between Vβ8+ and γδT-lymphocytes in contact sensitivity. Immunology. 93:469–477.
  • Drake L, Kita H. 2014. Group 2 innate lymphoid cells in the lung. Adv Immunol. 124:1–16.
  • Dudeck A, Dudeck J, Scholten J, Petzold A, Surianarayanan S, Kohler A, Peschke K, Vohringer D, Waskow C, Krieg T, et al. 2011. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity. 34:973–984.
  • Dudeck J, Medyukhina A, Frobel J, Svensson C, Kotrba J, Gerlach M, Gradtke A, Schroder B, Speier S, Figge M, et al. 2017. Mast cells acquire MHCII from dendritic cells during skin inflammation. J Exp Med. 214:3791–3811.
  • Esser P, Wolfle R, Durr C, von Loewenich F, Schempp C, Freudenberg M, Jakob T, Martin S. 2012. Contact sensitizers induce skin inflammation via ROS production and hyaluronic acid degradation. PLoS One. 7:e41340.
  • Evavold C, C. Kagan J. 2018. How inflammasomes inform adaptive immunity. J Mol Biol. 430:217–237.
  • Eyerich K, Eyerich S. 2015. TH22 cells in allergic disease. Allergo J Int. 24:1–7.
  • Faustin B, Lartigue L, Bruey J, Luciano F, Sergienko E, Bailly-Maitre B, Volkmann N, Hanein F, Rouiller I, Reed J. 2007. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell. 25:713–724.
  • Fujita H. 2013. The role of IL-22 and TH22 cells in human skin diseases. J Dermatol Sci. 72:3–8.
  • Fyhrquist N, Lehtimaki S, Lahl K, Savinko T, Lappetelainen A, Sparwasser T, Wolff H, Lauerma A, Alenius H. 2012. FoxP3+ cells control TH2 responses in a murine model of atopic dermatitis. J Invest Dermatol. 132:1672–1680.
  • Gaide O, Emerson R, Jiang X, Gulati N, Nizza S, Desmarais C, Robins H, Krueger J, Clark R, Kupper T. 2015. Common clonal origin of central and resident memory T cells following skin immunization. Nat Med. 21:647–653.
  • Galbiati V, Papale A, Galli C, Marinovich M, Corsini E. 2014. Role of ROS and HMGB1 in contact allergen-induced IL-18 production in human keratinocytes. J Invest Dermatol. 134:2719–2727.
  • Galli S, Hammel I. 1984. Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice. Science. 226:710–713.
  • Gilfillan A, Beaven M. 2011. Regulation of mast cell responses in health and disease. Crit Rev Immunol. 31:475–529.
  • Gimenez-Rivera V, Siebenhaar F, Zimmermann C, Siiskonen H, Metz M, Maurer M. 2016. Mast cells limit the exacerbation of chronic allergic contact dermatitis in response to repeated allergen exposure. J Immunol. 197:4240–4246.
  • Grimbaldeston M, Nakae S, Kalesnikoff J, Tsai M, Galli S. 2007. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol. 8:1095–1104.
  • Gulati N, Lovendorf M, Zibert J, Akat K, Renwick N, Tuschl T, Krueger J. 2015. Unique microRNAs appear at different times during the course of a delayed-type hypersensitivity reaction in human skin. Exp Dermatol. 24:953–957.
  • Halim T, Hwang Y, Scanlon S, Zaghouani H, Garbi N, Fallon P, McKenzie A. 2016. Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses. Nat Immunol. 17:57–64.
  • Hori S, Nomura T, Sakaguchi S. 2003. Control of regulatory T-cell development by the transcription factor FoxP3. Science. 299:1057–1061.
  • Hougaard M, Menné T, Søsted H. 2012. Occupational eczema and asthma in a hairdresser caused by hair-bleaching products. Dermatitis. 23:284–287.
  • Islam S, Luster A. 2012. T cell homing to epithelial barriers in allergic disease. Nat Med. 18:705–715.
  • Jarvis J, Seed M, Elton R, Sawyer L, Agius R. 2005. Relationship between chemical structure and the occupational asthma hazard of low molecular weight organic compounds. Occup Environ Med. 62:243–250.
  • Jia L, Wu C. 2014. The biology and functions of TH22 cells. Adv Exp Med Biol. 841:209–230.
  • Jiang X, Clark R, Liu L, Wagers A, Fuhlbrigge R, Kupper T. 2012. Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. Nature. 483:227–231.
  • Jiang X, Park C, Geddes Sweeney J, Yoo M, Gaide O, Kupper T. 2017. Dermal γδ T cells do not freely re-circulate out of skin and produce IL-17 to promote neutrophil infiltration during primary contact hypersensitivity. PLoS One. 12:e0169397.
  • Jin H, Kumar L, Mathias C, Zurakowski D, Oettgen H, Gorelik L, Geha R. 2009. Toll-like receptor 2 is important for the T(H)1 response to cutaneous sensitization. J Allergy Clin Immunol. 123:875–882.
  • Jones B, Chen J. 2006. Inhibition of IFN transcription by site-specific methylation during T-helper cell development. Embo J. 25:2443–2452.
  • Jones C, Gregory L, Causton B, Campbell G, Lloyd C. 2012. Activin A and TGFβ promote TH9 cell–mediated pulmonary allergic pathology. J Allergy Clin Immunol. 129:1000–1010.
  • Kabesch M. 2014. Epigenetics in asthma and allergy. Curr Opin Allergy Clin Immunol. 14:62–68.
  • Kanerva L, Alanko K, Jolanki R, Aalto-Korte K, Estlander T. 1999. Occupational allergic contact dermatitis from potassium persulfate. Cont Derm. 40:116–117.
  • Kasemsarn P, Bosco J, Nixon R. 2016. The role of the skin barrier in occupational skin diseases. Curr. Probl. Dermatol 49:135–143.
  • Kim B, Siracusa M, Saenz S, Noti M, Monticelli L, Sonnenberg G, Hepworth M, van Voorhees A, Comeau M, Artis D. 2013. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med. 5:170ra16.
  • Kimber I, Dearman R. 2005. What makes a chemical a respiratory sensitizer?. Curr Opin Allergy Clin Immunol. 5:119–124.
  • Kimber I, Travis M, Martin S, Dearman R. 2012. Immunoregulation of skin sensitization and regulatory T cells. Cont Derm. 67:179–183.
  • Kim H, Guan H, Zu G, Li H, Wu L, Feng X, Elmets C, Fu Y, Xu X. 2006. High-level expression of B7-H1 molecules by dendritic cells suppresses the function of activated T-cells and desensitizes allergen-primed animals. J Leukocyte Biol. 79:686–695.
  • Kligman A. 1966. The identification of contact allergens by human assay. II Factors influencing the induction and measurement of allergic contact dermatitis. J Invest Dermatol. 47:375–392.
  • Klonowski K, Williams K, Marzo A, Blair D, Lingenheld E, Lefrancois L. 2004. Dynamics of blood-borne CD8 memory T cell migration in vivo. Immunity. 20:551–562.
  • Knaysi G, Smith A, Wilson J, Wisniewski J. 2017. The skin as a route of allergen exposure: Part II. allergens and role of the microbiome and environmental exposures. Curr Allergy Asthma Rep. 17:7
  • Lee D, Agarwal S, Rao A. 2002. TH2 lineage commitment and efficient IL-4 production involves extended demethylation of the IL-4 gene. Immunity. 16:649–660.
  • Liu J, Harberts E, Tammaro A, Girardi N, Filler R, Fishelevich R, Temann A, Licona-Limon P, Girardi M, Flavell R, et al. 2014. IL-9 regulates allergen-specific TH1 responses in allergic contact dermatitis. J Invest Dermatol. 134:1903–1911.
  • Long C, Lukomska E, Marshall N, Nayak A, Anderson S. 2016. Potential inhibitory influence of miRNA 210 on regulatory T-cells during epicutaneous chemical sensitization. Genes. 8:1.
  • Long C, Marshall N, Lukomska E, Kashon M, Meade B, Shane H, Anderson S. 2016. A role for regulatory T-cells in a murine model of epicutaneous toluene diisocyanate sensitization. Toxicol Sci. 152:85–98.
  • Lovinsky-Desir S, Miller R. 2012. Epigenetics, asthma, and allergic diseases: A review of the latest advancements. Curr Allergy Asthma Rep. 12:211–220.
  • Luo Y, Zhou B, Zhao M, Tang J, Lu Q. 2014. Promoter demethylation contributes to TSLP over-expression in skin lesions of patients with atopic dermatitis. Clin Exp Dermatol. 39:48–53.
  • Ma L, Xue H, Guan X, Shu C, Zhang J, Yu J. 2014. Possible pathogenic role of T helper type 9 cells and interleukin (IL)-9 in atopic dermatitis. Clin Exp Immunol. 175:25–31.
  • Manel N, Unutmaz D, Littman D. 2008. The differentiation of human T(H)-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nat Immunol. 9:641–649.
  • Marshall N, Lukomska E, Long C, Kashon M, Sharpnack D, Nayak A, Anderson K, Meade B, Anderson S. 2015. Triclosan induces thymic stromal lymphopoietin in skin promoting TH2 allergic responses. Toxicol Sci. 147:127–139.
  • Marshall N, Lukomska E, Nayak A, Long C, Hettick J, Anderson S. 2017. Topical application of the anti-microbial chemical triclosan induces immunomodulatory responses through the S100A8/A9-TLR4 pathway. J Immunotoxicol. 14:50–59.
  • Martin S, Esser P, Weber F, Jakob T, Freudenberg M, Schmidt M, Goebeler M. 2011. Mechanisms of chemical-induced innate immunity in allergic contact dermatitis. Allergy. 66:1152–1163.
  • Martin S, Dudda J, Bachtanian E, Lembo A, Liller S, Durr C, Heimesaat M, Bereswill S, Fejer G, Vassileva R, et al. 2008. Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity. J Exp Med. 205:2151–2162.
  • Martinez-Gonzalez I, Steer C, Takei F. 2015. Lung ILC2s link innate and adaptive responses in allergic inflammation. Trends Immunol. 36:189–195.
  • Matheson J, Johnson V, Luster M. 2005. Immune mediators in a murine model for occupational asthma: Studies with toluene diisocyanate. Toxicol Sci. 84:99–109.
  • Mattick J, Makunin I. 2006. Non-coding RNA. Hum Mol Genet. 15 Spec No.1:R17-29.
  • McFadden J, Puangpet P, Basketter D, Dearman R, Kimber I. 2013. Why does allergic contact dermatitis exist?. Br J Dermatol. 168:692–699.
  • Mekori Y, Galli S. 1985. Undiminished immunologic tolerance to contact sensitivity in mast cell-deficient W/Wv and Sl/Sld mice. J Immunol. 135:879–885.
  • Mirchandani A, Besnard A, Yip E, Scott C, Bain C, Cerovic V, Salmond R, Liew F. 2014. Type 2 innate lymphoid cells drive CD4+ TH2 cell responses. J Immunol. 192:2442–2448.
  • Mirshafiey A, Simhag A, El Rouby N, Azizi G. 2015. T-helper 22 cells as a new player in chronic inflammatory skin disorders. Int J Dermatol. 54:880–888.
  • Myles I, Williams K, Reckhow J, Jammeh M, Pincus N, Sastalla I, Saleem D, Stone D, Datta S. 2016. Transplantation of human skin microbiota in models of atopic dermatitis. JCI Insight. 1:10.
  • Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I, Sekikawa K, Asano M, Iwakura Y. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity. 17:375–387.
  • Nakamura N, Tamagawa-Mineoka R, Ueta M, Kinoshita S, Katoh N. 2015. Toll-like receptor 3 increases allergic and irritant contact dermatitis. J Invest Dermatol. 135:411–417.
  • Nakatsuji T, Chen T, Two A, Chun K, Narala S, Geha R, Hata T, Gallo R. 2016. Staphylococcus aureus exploits epidermal barrier defects in atopic dermatitis to trigger cytokine expression. J Invest Dermatol. 136:2192–2200.
  • Nguyen R, Lee A. 2012. Allergic contanct dermatitis caused by isocyanates in resin jewellery. Cont Derm. 67:56–57.
  • Nielsen M, Witherden D, Havran W. 2017. γδ T cells in homeostasis and host defence of epithelial barrier tissues. Nat Rev Immunol. 17:733–745.
  • O'Brien R, Born W. 2015. Dermal γδ T cells-what have we learned?. Cell Immunol. 296:62–69.
  • Oliphant C, Hwang Y, Walker J, Salimi M, Wong S, Brewer J, Englezakis A, Barlow J, Hams E, Scanlon S, et al. 2014. MHC-II-mediated dialog between Group 2 innate lymphoid cells and CD4+ T-cells potentiates Type 2 immunity and promotes parasitic helminth expulsion. Immunity. 41:283–295.
  • Otsuka A, Nonomura Y, Kabashima K. 2016. Roles of basophils and mast cells in cutaneous inflammation. Semin Immunopathol. 38:563–570.
  • Ouyang B, Bernstein D, Lummus Z, Ying J, Boulet L, Cartier A, Gautrin D, Ho S. 2013. Interferon-γ promoter is hypermethylated in blood DNA from workers with confirmed diisocyanate asthma. Toxicol Sci. 133:218–224.
  • Oyoshi M, Murphy G, Geha R. 2009. Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J Allergy Clin Immunol. 124:485–493.
  • Padoan M, Pozzato V, Simoni M, Zedda L, Milan G, Bononi I, Piola C, Maestrelli P, Boschetto P, Mapp C. 2003. Long-term follow-up of toluene diisocyanate-induced asthma. Eur Respir J. 21:637–640.
  • Palm N, Medzhitov R. 2009. Immunostimulatory activity of haptenated proteins. Proc Natl Acad Sci USA. 106:4782–4787.
  • Palmer C, Irvine A, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee S, Goudie D, Sandilands A, Campbell L, Smith F, et al. 2006. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 38:441–446.
  • Palmer C, Ismail T, Lee S, Terron-Kwiatkowski A, Zhao Y, Liao H, Smith F, McLean W, Mukhopadhyay S. 2007. Filaggrin null mutations are associated with increased asthma severity in children and young adults. J Allergy Clin Immunol. 120:64–68.
  • Park C, Kupper T. 2015. The emerging role of resident memory T cells in protective immunity and inflammatory disease. Nat Med. 21:688–697.
  • Pawankar R. 2014. Allergic diseases and asthma: A global public health concern and a call to action. World Allergy Organ J. 7:12
  • Pedra J, Cassel S, Sutterwala S. 2009. Sensing pathogens and danger signals by the inflammasome. Curr Opin Immunol. 21:10–16.
  • Qu N, Xu M, Mizoguchi I, Furusawa J, Kaneko K, Watanabe K, Mizuguchi J, Itoh M, Kawakami Y, Yoshimoto T. 2013. Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases. Clin Dev Immunol. 2013:968549.
  • Ramirez-Valle F, Gray E, Cyster J. 2015. Inflammation induces dermal Vγ4+ γδT17 memory-like cells that travel to distant skin and accelerate secondary IL-17-driven responses. Proc Natl Acad Sci USA. 112:8046–8051.
  • Rebane A, Runnel T, Aab A, Maslovskaja J, Ruckert B, Zimmermann M, Plaas M, Karner J, Treis A, Pihlap M, et al. 2014. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. J Allergy Clin Immunol. 134:836–847.
  • Reber L, Sibilano R, Starkl P, Roers A, Grimbaldeston M, Tsai M, Gaudenzio N, Galli S. 2017. Imaging protective mast cells in living mice during severe contact hypersensitivity. JCI Insight. 2:9.
  • Redlich C. 2010. Skin exposure and asthma: Is there a connection?. Proc Am Thorac Soc. 7:134–137.
  • Roediger B, Kyle R, Yip K, Sumaria N, Guy T, Kim B, Mitchell A, Tay S, Jain R, Forbes-Blom E, et al. 2013. Cutaneous immunosurveillance and regulation of inflammation by Group 2 innate lymphoid cells. Nat Immunol. 14:564–573.
  • Ruwona T, Johnson V, Schmechel D, Simoyi R, Beezhold D, Siegel P. 2010. Monoclonal anti-bodies against toluene diisocyanate haptenated proteins from vapor-exposed mice. Hybridoma. 29:221–229.
  • Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 155:1151–1164.
  • Salimi M, Barlow J, Saunders S, Xue L, Gutowska-Owsiak D, Wang X, Huang L, Johnson D, Scanlon S, McKenzie A, et al. 2013. A role for IL-25 and IL-33-driven Type-2 innate lymphoid cells in atopic dermatitis. J Exp Med. 210:2939–2950.
  • Sanchez Rodriguez R, Pauli M, Neuhaus I, Yu S, Arron S, Harris H, Yang S, Anthony B, Sverdrup F, Krow-Lucal E, et al. 2014. Memory regulatory T cells reside in human skin. J Clin Invest. 124:1027–1036.
  • SanMiguel A, Meisel J, Horwinski J, Zheng Q, Grice E. 2017. Topical anti-microbial treatments can elicit shifts to resident skin bacterial communities and reduce colonization by Staphylococcus aureus competitors. Antimicrob Agents Chemother. 61:9.
  • Santoni G, Cardinali C, Morelli M, Santoni M, Nabissi M, Amantini C. 2015. Danger- and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons. J Neuroinflamm. 12:21.
  • Sasseville D. 2008. Occupational contact dermatitis. Allergy Asthma Clin Immunol. 4:59–65.
  • Schenkel J, Fraser K, Beura L, Pauken K, Vezys V, Masopust D. 2014. T cell memory. Resident memory CD8 T cells trigger protective innate and adaptive immune responses. Science. 346:98–101.
  • Schlapbach C, Gehad A, Yang C, Watanabe R, Guenova E, Teague J, Campbell L, Yawalkar N, Kupper T, Clark R. 2014. Human TH9 cells are skin-tropic and have autocrine and paracrine pro-inflammatory capacity. Sci Transl Med. 6:219ra8.
  • Schmidt M, Raghavan B, Muller V, Vogl T, Fejer G, Tchaptchet S, Keck S, Kalis C, Nielsen P, Galanos C, et al. 2010. Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel. Nat Immunol. 11:814–819.
  • Sehra S, Serezani A, Ocana J, Travers J, Kaplan M. 2016. Mast cells regulate epidermal barrier function and the development of allergic skin inflammation. J Invest Dermatol. 136:1429–1437.
  • Shane H, Lukomska E, Stefaniak A, Anderson S. 2017. Divergent hypersensitivity responses following topical application of the quaternary ammonium compound, didecyldimethylammonium bromide. J Immunotoxicol. 14:204–214.
  • Shaw P, Lamkanfi M, Kanneganti T. 2010. NOD-like receptor (NLR) signaling beyond the inflammasome. Eur J Immunol. 40:624–627.
  • Sojka D, Huang Y, Fowell D. 2008. Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target. Immunology. 124:13–22.
  • Sonkoly E, Janson P, Majuri M-L, Savinko T, Fyhrquist N, Eidsmo L, Xu N, Meisgen F, Wei T, Bradley M, et al. 2010. MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. J Allergy Clin Immunol. 126:581–589.
  • Suzuki H, Wang B, Shivji G, Toto P, Amerio P, Tomai M, Miller R, Sauder D. 2000. Imiquimod, a topical immune response modifier, induces migration of Langerhans cells. J Invest Dermatol. 114:135–141.
  • Thatcher T, Luzina I, Fishelevich R, Tomai M, Miller R, Gaspari A. 2006. Topical imiquimod treatment prevents UV-light induced loss of contact hypersensitivity and immune tolerance. J Invest Dermatol. 126:821–831.
  • Tomura M, Honda T, Tanizaki H, Otsuka A, Egawa G, Tokura Y, Waldmann H, Hori S, Cyster J, Watanabe T, et al. 2010. Activated regulatory T-cells are the major T-cell type emigrating from the skin during a cutaneous immune response in mice. J Clin Invest. 120:883–893.
  • Tordesillas L, Goswami R, Benede S, Grishina G, Dunkin D, Jarvinen K, Maleki S, Sampson H, Berin M. 2014. Skin exposure promotes a TH2-dependent sensitization to peanut allergens. J Clin Invest. 124:4965–4975.
  • Tsushima F, Iwai H, Otsuki N, Abe M, Hirose S, Yamazaki T, Akiba H, Yagita H, Takahashi Y, Omura K, et al. 2003. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses. Eur J Immunol. 33:2773–2782.
  • Vanoirbeek J, Tarkowski M, Vanhooren H, de Vooght V, Nemery B, Hoet P. 2006. Validation of a mouse model of chemical-induced asthma using trimellitic anhydride, a respiratory sensitizer, and dinitrochlorobenzene, a dermal sensitizer. J Allergy Clin Immunol. 117:1090–1097.
  • Vennegaard M, Bonefeld C, Hagedorn P, Bangsgaard N, Lovendorf M, Odum N, Woetmann A, Geisler C, Skov L. 2012. Allergic contact dermatitis induces up-regulation of identical microRNAs in humans and mice. Cont Derm. 67:298–305.
  • Wang Z, Mascarenhas N, Eckmann L, Miyamoto Y, Sun X, Kawakami T, di Nardo A. 2017. Skin microbiome promotes mast cell maturation by triggering stem cell factor production in keratinocytes. J Allergy Clin Immunol. 139:1205–1216.
  • Wang A, Xu N. 2015. New insights into T cells and their signature cytokines in atopic dermatitis. IUBMB Life. 67:601–610.
  • Watanabe H, Gaide O, Petrilli V, Martinon F, Contassot E, Roques S, Kummer J, Tschopp J, French L. 2007. Activation of the IL-1β-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol. 127:1956–1963.
  • Watanabe H, Gehrke S, Contassot E, Roques S, Tschopp J, Friedmann P, French L, Gaide O. 2008. Danger signaling through the inflammasome acts as a master switch between tolerance and sensitization. J Immunol. 180:5826–5832.
  • Weber F, Esser P, Muller T, Ganesan J, Pellegatti P, Simon M, Zeiser R, Idzko M, Jakob T, Martin S. 2010. Lack of the purinergic receptor P2X(7) results in resistance to contact hypersensitivity. J Exp Med. 207:2609–2619.
  • Weber F, Nemeth T, Csepregi J, Dudeck A, Roers A, Ozsvari B, Oswald E, Puskas L, Jakob T, Mocsai A, et al. 2015. Neutrophils are required for both the sensitization and elicitation phase of contact hypersensitivity. J Exp Med. 212:15–22.
  • Wisniewski J, Agrawal R, Minnicozzi S, Xin W, Patrie J, Heymann P, Workman L, Platts-Mills T, Song T, Moloney M, et al. 2013. Sensitization to food and inhalant allergens in relation to age and wheeze among children with atopic dermatitis. Clin Exp Allergy. 43:1160–1170.
  • Wollina U. 2017. Microbiome in atopic dermatitis. Clin Cosmet Investig Dermatol. 10:51–56.
  • Wong S, Tan A, Lam K. 2009. Functional hierarchy and relative contribution of CD28/B7 and ICOS/B7-H2 co-stimulatory pathways to T-cell-mediated delayed-type hypersensitivity. Cell Immunol. 256:64–71.
  • Xue L, Salimi M, Panse I, Mjosberg J, McKenzie A, Spits H, Klenerman P, Ogg G. 2014. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J Allergy Clin Immunol. 133:1184–1194.
  • Yadav M, Louvet C, Davini D, Gardner J, Martinez-Llordella M, Bailey-Bucktrout S, Anthony B, Sverdrup F, Head R, Kuster D, et al. 2012. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med. 209:1713–1722.
  • Yang Z, Zeng N, Wang C, Wang H, Huang P, Pan Y. 2017. MicroRNA-124 alleviates chronic skin inflammation in atopic eczema via suppressing innate immune responses in keratinocytes. Cell Immunol. 319:53–60.
  • Yang I, Schwartz D. 2012. Epigenetic mechanisms and the development of asthma. J Allergy Clin Immunol. 130(6):1243–55.
  • Yockey L, Demehri S, Turkoz M, Turkoz A, Ahern P, Jassim O, Manivasagam S, Kearney J, Gordon J, Kopan R. 2013. The absence of a microbiota enhances TSLP expression in mice with defective skin barrier but does not affect the severity of their allergic inflammation. J Invest Dermatol. 133:2714–2721.
  • Zeeuwen PLJM, Kleerebezem M, Timmerman HM, Schalkwijk J. 2013. Microbiome and skin diseases. Curr Opin Allergy Clin Immunol. 13:514–520.
  • Zeng X, Meyer C, Huang J, Newell E, Kidd B, Wei Y, Chien Y. 2014. Γδ T-cells recognize haptens and mount a hapten-specific response. E-Life. 3:e03609
  • Zhang H, Kong H, Zeng X, Guo L, Sun X, He S. 2014. Subsets of regulatory T cells and their roles in allergy. J Transl Med. 12:125
  • Zhao Y, Yang J, Shi J, Gong Y, Lu Q, Xu H, Liu L, Shao F. 2011. The NLRC4 inflammasome receptors for bacterial flagellin and Type III secretion apparatus. Nature. 477:596–600.
  • Zheng R, Yang Q. 2014. The role of the γδ T-cell in allergic diseases. J Immunol Res. 2014:963484
  • Zissler U, Esser-von Bieren J, Jakwerth C, Chaker A, Schmidt-Weber C. 2016. Current and future biomarkers in allergic asthma. Allergy. 71:475–494.